Understand the source comparison
Stacking DSIP Melatonin Sleep Architecture: Research vs Marketing Claims Comparison
'Deeper sleep in 30 minutes' No. DSIP CNS effects peak 60–90 min post-dose Delta-opioid receptor modulation has a 30–60 min onset lag after plasma peak Sleep-onset acceleration is melatonin's role, not DSIP's 'Safe to take both at bedtime' Suboptimal. Timing d
No winner is assigned.
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- 'Deeper sleep in 30 minutes'
- No. DSIP CNS effects peak 60–90 min post-dose
- Delta-opioid receptor modulation has a 30–60 min onset lag after plasma peak
- Sleep-onset acceleration is melatonin's role, not DSIP's
- 'Safe to take both at bedtime'
- Suboptimal. Timing determines synergy
- Concurrent dosing causes melatonin sleep-onset to precede DSIP's slow-wave window
- Sequential dosing (90 min gap) required for architectural effects
- 'Works like prescription sleep meds'
- Mechanistically distinct
- DSIP/melatonin modify sleep architecture without GABAergic sedation
- No rebound insomnia or tolerance buildup
- 'Increases total sleep time'
- Mixed. Extends slow-wave duration, not total time
- DSIP increases Stage 3 NREM proportion; melatonin consolidates REM but doesn't extend sleep beyond natural circadian limits
- Sleep quality improves more than quantity
- 'Melatonin 5–10mg is better'
- No. Receptor saturation occurs at 1–3mg
- MT1/MT2 receptors fully occupied at low doses; excess suppresses endogenous production
- 0.5–1mg sublingual is clinically optimal